People: Shire PLC (SHP.L)
23 Jan 2017
Mr. William Burns has been re-designated as Senior Non-Executive Independent Director of Shire Plc., effective 28 April 2016. He brings to the Board extensive international R&D, commercial, business development and operational experience in the pharmaceutical sector. He worked for Roche from 1986 until 2009; most recently holding the position of CEO of their pharmaceuticals division and serving as a member of the Roche Group Corporate Executive Committee. Bill holds a BA (Hons). Key appointments: Masters Pharmaceuticals (Chairman), Biotie Therapies Corp. (Chairman), Mesoblast Limited (Non-Executive Director), Vestergaard Frandsen (Vice Chairman), Wellcome Trust (Committee Chairman), Institute of Cancer Research (Trustee) and University of Cologne/Bonn Center for Integrated Oncology (Scientific Advisory Board Member).
|Total Annual Compensation, GBP||125,250|
|Restricted Stock Awards, GBP||--|
|Long-Term Incentive Plans, GBP||--|
|All Other, GBP||--|
|Fiscal Year Total, GBP||125,250|